##  [Novartis positive 52-week PREVENT data confirm Cosentyx® efficacy in addressing entire axSpA spectrum](/us-en/news/media-releases/novartis-positive-52-week-prevent-data-confirm-cosentyx-efficacy-addressing-entire-axspa-spectrum-0 "Novartis positive 52-week PREVENT data confirm Cosentyx® efficacy in addressing entire axSpA spectrum") 

  Oct 02, 2019